APEX Ipamorelin, CJC-1295 10MG / 10MG Blend (no DAC)
Product Specifications
Compound: Ipamorelin, CJC- 1295 5MG / 5MG Blend (no DAC)
Strength: 10MG / 10MG
Form: Lyophilized powder
Quality Assurance: Third-party tested for purity and integrity
Brand: Apex Performance Peptides Labs
APEX Ipamorelin and CJC-1295 no DAC (Mod GRF 1-29) are synthetic research peptides used together in experimental models to study growth hormone axis regulation and pituitary signaling dynamics. Ipamorelin is a selective pentapeptide growth hormone secretagogue that acts as an agonist of the growth hormone secretagogue receptor (GHS-R1a), activating Gq/PLC and calcium-dependent signaling pathways involved in GH release while exhibiting minimal interaction with other pituitary hormones in preclinical systems. CJC-1295 no DAC is a stabilized analog of growth hormone–releasing hormone (GHRH 1-29) that activates the GHRH receptor, stimulating adenylate cyclase and cAMP-mediated signaling in somatotroph cells. Preclinical research employs the combined activation of GHS-R1a and GHRH receptors to investigate synergistic somatotropic signaling, hypothalamic–pituitary feedback mechanisms, and peptide-mediated endocrine regulation.
For research use only. Not for human consumption.
References: Bowers CY et al., Ann NY Acad Sci, 1998 865:244–249
Frohman LA et al., Endocr Rev, 2001 22(6):606–648
Svensson J et al., J Endocrinol Invest, 1998 21(9):692–699
){kind=link}